2m 2m 2m 2m 2m 2m 2m
Cytodyn (CYDY)
OTC
$0.20+$0.001 (+0.50%)
Price as of Oct 02, 2026- $293.9MMarket Cap
- -23.08%1-Year Change
- BiotechnologyIndustry
Cytodyn (CYDY)
$0.20+$0.001 (+0.50%)
CYDY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.20 | ||
Change | +$0.001 (+0.50%) | ||
Open | $0.19 | ||
High | $0.21 | ||
Low | $0.19 | ||
Previous Close | $0.20 | ||
Volume | 1,527,711 | ||
30-Day Average Volume | 1,653,865 | ||
1-Week Change | -11.89% | ||
1-Month Change | -4.31% | ||
1-Year Change | -23.08% | ||
3-Year Change | 7.82% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.5B | ||
Total Assets | $14.0M | ||
Market Cap | $293.9M | ||
Enterprise Value | $309.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$9.9M | ||
Free Cash Flow | -$4.9M | ||
EBIT | -$9.9M | ||
EBITDA | -$9.9M | ||
Net Working Capital | -$39.8M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -3 | ||
P/E | -28 | ||
PEG | N/A | ||
Price/Free Cash Flow | -60 | ||
Price/Operating Cash Flow | -60 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue